Mydri Atropine 1% (Ophthalmic Ointment)
4 gm tube: ৳ 25.00
Medicine Details
Category | Details |
---|---|
Generic | Atropine sulfate ophthalmic |
Company | Reman drug laboratories ltd |
Also available as |
Product Title
- Mydri Mydri Atropine Eye Drops
Categories
- Ophthalmic Medication
- Myopia Treatment
- Cycloplegic Agent
- Mydriatic Agent
- Eye Health
Description
- This medication is used for cycloplegic or mydriatic purposes, to slow the progression of myopia in children aged 4 to 14 years, and for desired dilatation of the iris or uveal tract during acute inflammatory conditions.
Dosage Form
- Eye Drops
Strength
- 1%
- 0.01%
Composition
- Atropine Sulphate BP 10 mg per ml
- Atropine Sulphate USP 0.1 mg per ml
Preservative
- Benzalkonium Chloride 0.01%
- Sodium Perborate 0.01%
Pharmacological Action
- Suppression of myopia progression
- Binding to muscarinic receptors
- Changes in cell signaling proteins and enzymes
- Scleral remodeling or strengthening
- Reduction in axial length and vitreous chamber depth
Recommended Usage
- One drop three times daily for uveitis
- One drop in the eyes twice daily for refraction
- One drop to each eye at night for myopia treatment
Interaction
- Anticholinergics
- Antiglaucoma agents
- Potassium Citrate
- Potassium Supplements
- Carbachol
- Physostigmine
- Pilocarpine
- CNS medication
Contraindications
- Angle closure glaucoma or suspected angle closure glaucoma
Side Effects
- Blurred vision
- Local irritation
- Follicular conjunctivitis
- Vascular congestion
- Edema
- Contact dermatitis
- Photophobia
Pregnancy & Lactation
- Systemic absorption after ocular administration
- Distribution into breast milk in small amounts
- Adverse effects on nursing infant
- Rapid pulse, fever or dry skin in nursing infant
Precautions & Warnings
- Not for children who previously had severe systemic reaction to Mydri Mydri Atropine
- Increased susceptibility in children with Down's syndrome, spastic paralysis, or brain damage
- Regular eye health clinical reviews required for long term treatment
- Not for children less than 4 years old
Overdose Effects
- Headache
- Fast heartbeat
- Dry mouth and skin
- Unusual drowsiness
- Flushing
Therapeutic Class
- Mydriatic and Cycloplegic Agents
Storage Conditions
- Store below 30°C in a dry place away from light
- Do not touch the dropper bottle tip to avoid contamination
- Do not use after 1 month of opening
Packaging
- Dropper Bottle
Related Brands
- Aristopin 0.01% (Ophthalmic Solution) - aristopharma-ltd
- Atrogen M 0.01% (Ophthalmic Solution) - general-pharmaceuticals-ltd
- Kidopia 0.01% (Ophthalmic Solution) - popular-pharmaceuticals-ltd
- Itropin 1% (Ophthalmic Solution) - nipa-pharmaceuticals-ltd
- Ocupin 1% (Ophthalmic Ointment) - osl-pharma-limited